Cargando…
An Inflection Point in Cancer Protein Biomarkers: What was and What's Next
Biomarkers remain the highest value proposition in cancer medicine today—especially protein biomarkers. Despite decades of evolving regulatory frameworks to facilitate the review of emerging technologies, biomarkers have been mostly about promise with very little to show for improvements in human he...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388583/ https://www.ncbi.nlm.nih.gov/pubmed/37196763 http://dx.doi.org/10.1016/j.mcpro.2023.100569 |